- Investing.com
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counselling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
Market Outlook | Analyst price targets range from $9 to $20, reflecting mixed sentiments on Teladoc's ability to overcome hurdles and capitalize on its established infrastructure |
Strategic Shift | Learn about Teladoc's new leadership and upcoming initiatives aimed at addressing operational challenges and charting a course for future growth |
Financial Crossroads | Delve into Teladoc's recent financial performance, including revenue challenges, subscriber declines, and high customer acquisition costs impacting profitability |
Virtual Care Pionee | Explore Teladoc's position as a leader in telemedicine, offering a range of services from telehealth consultations to AI-driven analytics in a rapidly evolving secto |
Metrics to compare | TDOC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTDOCPeersSector | |
---|---|---|---|---|
P/E Ratio | −1.3x | 12.6x | −0.5x | |
PEG Ratio | 0.00 | 0.02 | 0.00 | |
Price / Book | 0.9x | 2.1x | 2.6x | |
Price / LTM Sales | 0.5x | 1.4x | 3.0x | |
Upside (Analyst Target) | 10.2% | 30.4% | 54.7% | |
Fair Value Upside | Unlock | 13.9% | 8.4% | Unlock |